Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Royal Marsden NHS Foundation Trust · Royal Surrey County Hospital · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
728
total citations
- FWCI
- 63.28
- Percentile
- 100%
- References
- 36
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Medicine
- Capecitabine
- Panitumumab
- Epirubicin
- Oxaliplatin
- Internal medicine
- Clinical endpoint
- Population
UN Sustainable Development Goals
- No poverty
No related works found for this paper.